EXOZ (EXOZ) reported R&D of $1.12M in Q1 2026.

How has EXOZ's R&D changed year-over-year?

EXOZ's R&D increased by 95.0% year-over-year, from $575.02K to $1.12M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

EXOZ EXOZ R&D

R&D at other companies

GevoGEVO

$1.5M+42.5%

Ginkgo BioworksDNA

$49.92M-29.6%

NAG

Niagen Bioscience, Inc. Common StockNAGE

$1.48M+17.7%

Opko HealthOPK

$29.2M-5.3%

West Pharmaceutical ServicesWST

$15.8M-3.1%

Other financials

Income statement

See full

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

See full

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

See full

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

See full

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

See full

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

See full

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EXOZ's R&D?: EXOZ (EXOZ) reported R&D of $1.12M in Q1 2026.
How has EXOZ's R&D changed year-over-year?: EXOZ's R&D increased by 95.0% year-over-year, from $575.02K to $1.12M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.